ARCHIVES

Variation in Breast Density May Be Strong Risk Factor

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

Panitumumab Improves PFS In Metastatic Colon Cancer

April 28, 2006

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

Bypass Budget Seeks Double Funding for Breast Cancer Research

November 6, 1992

Advisors Approve Program To Link Radiation Oncologists.

June 29, 2001

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

June 11, 2014